P.2.c.003 A placebo-controlled study of EB-1010, a novel triple re-uptake inhibitor, in patients with major depressive disorder
P. Tran, M. Bradshaw, A. McKinney, F. Bymaster, P. Skolnick, P. Czobor, N. Huang, J. Manthis, M. FavaVolume:
21
Year:
2011
Language:
english
DOI:
10.1016/s0924-977x(11)70617-4
File:
PDF, 69 KB
english, 2011